Published in Br J Cancer on April 28, 2009
Real-time Cancer Pain Assessment and Intervention | NCT01914107
Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer. J Clin Oncol (2012) 3.65
Impact of cabazitaxel on 2-year survival and palliation of tumour-related pain in men with metastatic castration-resistant prostate cancer treated in the TROPIC trial. Ann Oncol (2013) 1.76
Assessing and treating pain in hospices: current state of evidence-based practices. J Pain Symptom Manage (2010) 1.01
Pain in castration-resistant prostate cancer with bone metastases: a qualitative study. Health Qual Life Outcomes (2011) 0.96
Opioid requirement, opioid receptor expression, and clinical outcomes in patients with advanced prostate cancer. Cancer (2013) 0.94
Predictive factors for overall quality of life in patients with advanced cancer. Support Care Cancer (2013) 0.94
Recent advances in the treatment of pain. F1000 Med Rep (2010) 0.86
Pain in blood cancers. Indian J Palliat Care (2011) 0.83
Opioid use and effectiveness of its prescription at discharge in an acute pain relief and palliative care unit. Support Care Cancer (2013) 0.80
Characteristics and associations of pain intensity in patients referred to a specialist cancer pain clinic. Pain Res Manag (2015) 0.80
A prospective, open-label, multicenter study of the clinical efficacy of extended-release hydromorphone in treating cancer pain inadequately controlled by other analgesics. Support Care Cancer (2013) 0.80
Access to opioid analgesics and pain relief for patients with cancer. Nat Rev Clin Oncol (2013) 0.78
Assessing the response to opioids in cancer patients: a methodological proposal and the results. Support Care Cancer (2014) 0.78
Pain outcomes in patients with bone metastases from advanced cancer: assessment and management with bone-targeting agents. Support Care Cancer (2014) 0.78
Inadequate pain management in cancer patients attending an outpatient palliative radiotherapy clinic. Support Care Cancer (2015) 0.78
Determinants of pain severity changes in ambulatory patients with cancer: an analysis from Eastern Cooperative Oncology Group trial E2Z02. J Clin Oncol (2013) 0.78
Cancer pain management in an oncological ward in a comprehensive cancer center with an established palliative care unit. Support Care Cancer (2013) 0.77
Managing severe cancer pain: the role of transdermal buprenorphine: a systematic review. Ther Clin Risk Manag (2009) 0.77
Does a regional comprehensive palliative care program improve pain in outpatient cancer patients? Support Care Cancer (2014) 0.76
Rationale, design, and implementation protocol of the Dutch clinical practice guideline pain in patients with cancer: a cluster randomised controlled trial with Short Message Service (SMS) and Interactive Voice Response (IVR). Implement Sci (2011) 0.76
Efficacy of an intrathecal multidrug infusion for pain control in older adults and in end-stage malignancies: A report of three cases. Pain Res Manag (2015) 0.75
Cancer pain--progress and ongoing issues in Europe. Pain Res Manag (2009) 0.75
Could Perioperative Opioid Use Increase the Risk of Cancer Progression and Metastases? Int Anesthesiol Clin (2016) 0.75
Oxycodone/naloxone as a therapeutic option in a patient with chronic pain and opioid-induced bowel dysfunction. Contemp Oncol (Pozn) (2014) 0.75
The Italian cross-sectional survey of the management of bone metastasis: ZeTa study. J Bone Oncol (2012) 0.75
Reply-Letter to the Editor: What to Do, and What Not to Do, When Diagnosing and Treating Breakthrough Cancer Pain (BTcP): Expert Opinion. Drugs (2016) 0.75
The effectiveness of the quality program Pac-IficO to improve pain management in hospitalized cancer patients: a before-after cluster phase II trial. BMC Palliat Care (2014) 0.75
Adequacy of cancer-related pain management and predictors of undertreatment at referral to a pain clinic. J Pain Res (2017) 0.75
Health-related quality of life effects of enzalutamide in patients with metastatic castration-resistant prostate cancer: an in-depth post hoc analysis of EQ-5D data from the PREVAIL trial. Health Qual Life Outcomes (2017) 0.75
Pain and its treatment in outpatients with metastatic cancer. N Engl J Med (1994) 9.54
Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol (2007) 6.35
Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol (2008) 4.70
Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer (2001) 3.40
The role of chemotherapy at the end of life: "when is enough, enough?". JAMA (2008) 3.31
Opioid purchases and expenditure in nine western European countries: 'are we killing off morphine?'. Palliat Med (2005) 2.32
A validation study of the WHO method for cancer pain relief. Cancer (1987) 2.32
Pain treatment and outcomes for patients with advanced cancer who receive follow-up care at home. Cancer (1999) 1.77
Bisphosphonates for the relief of pain secondary to bone metastases. Cochrane Database Syst Rev (2002) 1.73
New clinical-practice guidelines for the management of pain in patients with cancer. N Engl J Med (1994) 1.70
Implementing guidelines for cancer pain management: results of a randomized controlled clinical trial. J Clin Oncol (1999) 1.39
Assessment of cancer pain: a prospective evaluation in 2266 cancer patients referred to a pain service. Pain (1996) 1.37
Simultaneous care: a model approach to the perceived conflict between investigational therapy and palliative care. J Pain Symptom Manage (2004) 1.33
Cancer pain management and the JCAHO's pain standards: an institutional challenge. J Pain Symptom Manage (2003) 1.28
A validation study of an Italian version of the Brief Pain Inventory (Breve Questionario per la Valutazione del Dolore). Pain (1996) 1.22
Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer. Br J Cancer (2004) 1.20
Opioids, pain, and fear. Ann Oncol (2007) 1.15
Empirical comparison of commonly used measures to evaluate pain treatment in cancer patients with chronic pain. J Clin Oncol (1999) 1.14
An assessment of methods used to evaluate the adequacy of cancer pain management. J Pain Symptom Manage (2006) 0.97
Pain management in hospitalized cancer patients: a systematic review. J Clin Oncol (2007) 0.95
Pain management: a review of organisation models with integrated processes for the management of pain in adult cancer patients. J Clin Nurs (2008) 0.95
A multidisciplinary project to improve the quality of cancer pain management in Italy: background, methods, and preliminary results. J Ambul Care Manage (2006) 0.95
Pain in cancer. An outcome research project to evaluate the epidemiology, the quality and the effects of pain treatment in cancer patients. Health Qual Life Outcomes (2006) 0.93
Factors influencing the decision to take or reject opioids for cancer pain: are we on target? Ann Oncol (2008) 0.80
The European mesothelioma epidemic. Br J Cancer (1999) 6.28
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol (2008) 4.70
Intake of macronutrients and risk of breast cancer. Lancet (1996) 2.81
European cancer mortality predictions for the year 2013. Ann Oncol (2013) 2.71
Epidemiology of biliary tract cancers: an update. Ann Oncol (2008) 2.51
Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx, and esophagus in northern Italy. Cancer Res (1990) 2.49
Trends in mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world. Heart (2002) 2.34
A validation study of the WHO method for cancer pain relief. Cancer (1987) 2.32
Cancer mortality in Europe, 2000-2004, and an overview of trends since 1975. Ann Oncol (2009) 2.20
Alcohol drinking and cutaneous melanoma risk: a systematic review and dose-risk meta-analysis. Br J Dermatol (2014) 2.15
Pooled analysis of 3 European case-control studies of ovarian cancer: II. Age at menarche and at menopause. Int J Cancer (1991) 2.14
Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study. J Clin Oncol (1995) 2.09
The rise and fall in primary liver cancer mortality in Italy. Dig Liver Dis (2002) 2.09
Light alcohol drinking and cancer: a meta-analysis. Ann Oncol (2012) 2.04
Childhood cancer mortality in Italy. Lancet (1996) 2.02
Dietary glycemic index and glycemic load, and breast cancer risk: a case-control study. Ann Oncol (2001) 1.95
Fish consumption and cancer risk. Am J Clin Nutr (1999) 1.94
Cancer mortality in the European Union, 1970-2003, with a joinpoint analysis. Ann Oncol (2008) 1.91
Fertility drugs and risk of epithelial ovarian cancer in Italy. Hum Reprod (1994) 1.91
Paraplegia following coeliac plexus block. Pain (1993) 1.85
Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies. Ann Oncol (2011) 1.84
Family history and the risk of stomach and colorectal cancer. Cancer (1992) 1.83
Western and eastern European trends in testicular cancer mortality. Lancet (2001) 1.80
Cancer mortality in Europe, 2005-2009, and an overview of trends since 1980. Ann Oncol (2013) 1.79
A case-control study of diabetes mellitus and cancer risk. Br J Cancer (1994) 1.76
Lung cancer mortality in European women: recent trends and perspectives. Ann Oncol (2005) 1.73
A pooled analysis of thyroid cancer studies. V. Anthropometric factors. Cancer Causes Control (2000) 1.70
Intake of selected micronutrients and risk of colorectal cancer. Int J Cancer (1997) 1.68
The role of reproductive and menstrual factors in cancer of the breast before and after menopause. Eur J Cancer (1996) 1.67
Trends of cancer mortality in Europe, 1955-1989: II, Respiratory tract, bone, connective and soft tissue sarcomas, and skin. Eur J Cancer (1992) 1.66
An update of cancer mortality among chrysotile asbestos miners in Balangero, northern Italy. Br J Ind Med (1990) 1.65
Pancreatitis and the risk of pancreatic cancer. Pancreas (1995) 1.64
Validation of a food-frequency questionnaire to assess dietary intakes in cancer studies in Italy. Results for specific nutrients. Ann Epidemiol (1996) 1.64
Short term increase in risk of breast cancer after full term pregnancy. BMJ (1988) 1.63
Paclitaxel in metastatic breast cancer: a trial of two doses by a 3-hour infusion in patients with disease recurrence after prior therapy with anthracyclines. J Natl Cancer Inst (1995) 1.63
A meta-analysis on alcohol drinking and gastric cancer risk. Ann Oncol (2011) 1.62
Olive oil, other dietary fats, and the risk of breast cancer (Italy). Cancer Causes Control (1995) 1.61
Rb family proteins as modulators of gene expression and new aspects regarding the interaction with chromatin remodeling enzymes. Oncogene (2006) 1.60
Trends in mortality from major diseases in Europe, 1980-1993. Eur J Epidemiol (1998) 1.59
A meta-analysis on alcohol drinking and esophageal and gastric cardia adenocarcinoma risk. Ann Oncol (2011) 1.57
Trends in cancer mortality in the Americas, 1970-2000. Ann Oncol (2005) 1.57
Octreotide in relieving gastrointestinal symptoms due to bowel obstruction. Palliat Med (1993) 1.57
Reliability of data on medical conditions, menstrual and reproductive history provided by hospital controls. J Clin Epidemiol (2001) 1.56
Smoking in Italy, 1986-1987. Tumori (1989) 1.55
Epidemiology and prevention of oral cancer. Oral Oncol (1997) 1.53
European cancer mortality predictions for the year 2012. Ann Oncol (2012) 1.52
Sex differences in colorectal cancer mortality in Europe, 1955-1996. Eur J Cancer Prev (2000) 1.52
Trends in mortality from suicide, 1965-99. Acta Psychiatr Scand (2003) 1.50
A pooled analysis of case-control studies of thyroid cancer. IV. Benign thyroid diseases. Cancer Causes Control (1999) 1.50
Worldwide trends in cancer mortality in the elderly, 1955-1992. Eur J Cancer (1996) 1.49
Coffee drinking and prevalence of bronchial asthma. Chest (1988) 1.46
Reliability of information on cigarette smoking and beverage consumption provided by hospital controls. Epidemiology (1996) 1.46
Risk factors for endometrioid, mucinous and serous benign ovarian cysts. Int J Epidemiol (1989) 1.45
Alcohol drinking and prevalence of self-reported gallstone disease in the 1983 Italian National Health Survey. Epidemiology (1994) 1.45
Association between certain foods and risk of acute myocardial infarction in women. BMJ (1990) 1.45
A pooled analysis of case-control studies of thyroid cancer. III. Oral contraceptives, menopausal replacement therapy and other female hormones. Cancer Causes Control (1999) 1.45
Long-term impact of reproductive factors on cancer risk. Int J Cancer (1993) 1.45
The fall in breast cancer mortality in Europe. Eur J Cancer (2001) 1.44
Reproducibility of an Italian food frequency questionnaire for cancer studies: results for specific food items. Eur J Cancer (1993) 1.44
Oral contraceptives and colorectal cancer risk: a meta-analysis. Br J Cancer (2001) 1.42
Dietary factors and the risk of endometrial cancer. Cancer (1993) 1.41
Familial spasmodic dysphonia with low arylsulphatase A (ASA) level. Acta Neurol Scand (1995) 1.40
Antidepressant drug use in Italy since the introduction of SSRIs: national trends, regional differences and impact on suicide rates. Soc Psychiatry Psychiatr Epidemiol (1999) 1.40
Family history and the risk of liver, gallbladder, and pancreatic cancer. Cancer Epidemiol Biomarkers Prev (1994) 1.39
Risk factors for breast cancer in women under 40 years. Eur J Cancer (1999) 1.38
Careful monitoring of the use of sedative drugs at the end of life: the role of Epidemiology. The ITAELD study. Minerva Anestesiol (2014) 1.38
Combined effect of tobacco and alcohol on laryngeal cancer risk: a case-control study. Cancer Causes Control (2002) 1.38
Reproductive factors and risk of uterine fibroids. Epidemiology (1996) 1.36
Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4). Ann Oncol (2011) 1.36
Cervical cancer mortality in young women in Europe: patterns and trends. Eur J Cancer (2000) 1.36
European cancer mortality predictions for the year 2011. Ann Oncol (2011) 1.35
Body size and colorectal-cancer risk. Int J Cancer (1998) 1.34
Epidemiologic characteristics of women with uterine fibroids: a case-control study. Obstet Gynecol (1988) 1.33
General epidemiology of breast cancer in northern Italy. Int J Epidemiol (1987) 1.32
Metabolic syndrome and the risk of breast cancer in postmenopausal women. Ann Oncol (2011) 1.29
Alcohol consumption and pancreatic cancer: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol (2011) 1.29
Trends in mortality from coronary heart and cerebrovascular diseases in the Americas: 1970-2000. Heart (2006) 1.29
Food groups and risk of squamous cell esophageal cancer in northern Italy. Int J Cancer (2000) 1.29
Influence from genetic variability on opioid use for cancer pain: a European genetic association study of 2294 cancer pain patients. Pain (2011) 1.28
Trends of cancer mortality in Europe, 1955-1989: I, Digestive sites. Eur J Cancer (1992) 1.26
Dietary glycemic load and colorectal cancer risk. Ann Oncol (2001) 1.25
Mortality from major cancer sites in the European Union, 1955-1998. Ann Oncol (2003) 1.24
Fertility drugs and the risk of breast cancer. Hum Reprod (1999) 1.23
Medical history, diet and pancreatic cancer. Oncology (1990) 1.22
Genital and urinary tract diseases and bladder cancer. Cancer Res (1991) 1.21
Red meat intake and cancer risk: a study in Italy. Int J Cancer (2000) 1.21
Risk factors for hepatocellular carcinoma in northern Italy. Int J Cancer (1988) 1.21
Metabolic syndrome and endometrial cancer risk. Ann Oncol (2010) 1.20
Reproductive factors and the risk of invasive and intraepithelial cervical neoplasia. Br J Cancer (1989) 1.20
Body size indices and breast cancer risk before and after menopause. Int J Cancer (1996) 1.20
Food and nutrient intake and risk of cataract. Ann Epidemiol (1996) 1.20
Role of family history in patients with myocardial infarction. An Italian case-control study. GISSI-EFRIM Investigators. Circulation (1992) 1.20
Food groups, oils and butter, and cancer of the oral cavity and pharynx. Br J Cancer (1999) 1.19
Body mass index and post-menopausal breast cancer: an age-specific analysis. Br J Cancer (1997) 1.19
Dietary factors and the risk of epithelial ovarian cancer. J Natl Cancer Inst (1987) 1.18
Selected medical conditions and risk of breast cancer. Br J Cancer (1997) 1.18
Cancer mortality in a cohort of asbestos textile workers. Br J Cancer (2005) 1.18
The suppurative abscess of an endometriosic ovarian cyst due to Salmonella brandenburg. Infection (1982) 1.18